메뉴 건너뛰기




Volumn 359, Issue 9323, 2002, Pages 2105-2107

Differential pricing of drugs: A role for cost-effectiveness analysis?

Author keywords

[No Author keywords available]

Indexed keywords

ACERIL; ALAPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDNIT; ENALAPRIL; ENALAPRIL MALEATE; ENAP 20; ENAP KRKA; ENAPIREX; HYDROCHLOROTHIAZIDE; INVORIL; IRUMED; LISINOPRIL; THIAZIDE DIURETIC AGENT; VASOPREN;

EID: 0037097042     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08911-0     Document Type: Article
Times cited : (30)

References (19)
  • 7
    • 18044399458 scopus 로고    scopus 로고
    • Drug company to sell AIDS drugs at less than cost price
    • (2001) BMJ , vol.322 , pp. 692
    • Gottlieb, S.1
  • 8
    • 85031455428 scopus 로고    scopus 로고
  • 9
    • 0033501110 scopus 로고    scopus 로고
    • Essential drugs: WHO model list (revised December 1999)
    • (1999) WHO Drug Information , vol.13 , pp. 249-262
  • 10
    • 85031453663 scopus 로고    scopus 로고
  • 11
    • 85031456247 scopus 로고    scopus 로고
  • 12
    • 0034627183 scopus 로고    scopus 로고
    • Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
    • (2000) Lancet , vol.355 , pp. 1955-1964
  • 13
    • 0025913812 scopus 로고
    • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
    • (1991) N Engl J Med , vol.325 , pp. 293-302


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.